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Abstract 
The aim of present study is to develop biodegradable microspheres of 
Tinidazole. Bovine Serum Albumin was used for the preparation of 
microspheres. They were made in four batches. The emulsion cross-linking 
method was used for the preparation. The quantity of BSA varies for each 
formulation. Formulations were evaluated for particle size, Melting point, 
TLC, entrapment efficiency and in vitro release studies. Depending upon the 
drug to polymer ratio, the entrapment, loading were found to range between 
48, 55, 75 and 78 (in %) respectively. Particle size of prepared microspheres 
was measured using a compound microscope. The surface topography and 
internal textures of the microspheres was observed by scanning electron 
microscopy. The microspheres were spherical, discrete and compact and size 
distribution was between 33.28 to 36.25 µm. In vitro studies were carried out 
at different pH for a period of 18 h and compared with marketed formulation. 
From all the batches it is concluded that when concentration of polymer 
increases microspheres shows more controlled and prolonged release. The 
drug release was between 66, 51, 48, 42 (in %). The drug release from 1:4 is 
most prolonged and constant. Both the IR spectra of drug and formulation 
were almost same. Combination multitone recorded due to N=O stretching 
and S=O in the IR region of 1500-1250 cm−1. 
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Introduction  
Microspheres come under controlled drug delivery 
system. Microspheres are characteristically free 
flowing powders consist of protein/synthetic polymer 
which are biodegradable in nature and ideally having 
particle size less than 200µm. Solid biodegradable 
microspheres incorporating a drug dispersed or 
dissolved throughout particle matrix have the potential 
for the control release of drug [1]. 
 
 
Microspheres have been extensively studied for use as 
drug delivery systems, where they have been shown to 
protect sensitive macromolecules from enzymatic and 
acid degradation, and allow controlled release and 
tissue targeting of the formulated drug [2]. Tinidazole 
is a nitroimidazole derivative, antiparasitic drug used 
against protozoan infection. It has broad spectrum cidal 
activity against protozoa including Giardia Lamblia 
many anaerobic bacteria such as fragilis, 
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fusobacterium, clostridium Perfrigens, cldifficile, 
Helicobacter pylori. Its elimination half life is 12 hours 
[3]. 
 
Materials and methods 
Tinidazole was obtained as gift sample from FDC 
limited Mumbai. Bovine serum albumin, Span 80, 
glutaraldehyde and toluene were obtained from 
commercial sources and were of analytical grade. 
 
Preparation of microspheres of tinidazole 
BSA microspheres containing tinidazole were prepared 
by the emulsion technique. An aqueous solution of 
BSA (20 % w/v) was adjusted to PH 10.Take 1ml.of 
BSA solution and to this add 0.1gm of tinidazole and 
dissolve. This solution was dispersed in a 
10ml.solution of span 80 in toluene (13 %) by 
vortexing. This dispersed solution is stirred at 300rpm 
and gradually added to 0.5-1ml.of glutaraldehyde in 
distilled water (10 %), which was maintained at PH 
10.After initial cross linking, add 20 ml. of acetone 
with continuous stirring for 5 hours. The microspheres 
formed were washed with acetone five times and with 
water three times and then dried to get free flowing 
microspheres in a powder form. By varying the drug: 
polymer ratio, five batches of microspheres were 
prepared [4]. 
 
Table1. Composition of tinidazole microspheres. 
 
Batch code Drug: polymer 
A-1 1:1 
A-2 1:2 
A-3 1:3 
A-4 1:4 
 
Physicochemical evaluation of the microspheres 
Size analysis 
Particle size of prepared microspheres was measured 
using a compound microscope and the mean particle 
size was calculated by measuring 100 particles with the 
help of a calibrated ocular micrometer. 
 
Morphology 
The surface topography and internal textures of the 
microspheres was observed by scanning electron 
microscopy. 
 
Melting point 
Microspheres were taken and placed within melting 
point apparatus inside the capillary. Microspheres were 
sufficiently heated to get their melting point. 
 
Thin layer chromatography 
A pure sample of tinidazole 5 mg was dissolved in 
0.5%w/v solution of ammonium carbonate to produce 
4.17ml.Similarily, 5 mg equivalent tinidazole 
microspheres and 5 mg of BSA were separately 
dissolved in 0.5 % w/v solution of ammonium 
carbonate. These solutions were spotted in a TLC Plate 
and marked. Then the plate was placed in closed vessel 
containing 15.6 % w/v solution of sodium dihydrogen 
phosphate adjusted to PH 4.8 with sodium hydroxide 
solution as the mobile phase. The developed spots were 
noted and Rf value were measured. The drug stability 
was studied by means of comparison of Rf values [4]. 
 
Drug content determination 
Microspheres thoroughly triturated and suspended in 
minimal amount of alcohol. This suspension is diluted 
with water and this is then filtered to separate shell 
fragments and drug content was analyzed by UV 
Spectrophotometer at 366.4 nm [5]. 
 
                              Drug content in microspheres 
% incorporation =                                                  ×100 
                           Drug included in the formulation 
 
In vitro drug release 
In vitro release profile of tinidazole microspheres from 
the preparations was examined in pH 1.2 buffer from 0-
2 hr, in pH 4.5 phosphate buffer from 2 to 4 h and in 
phosphate buffer pH 7.2 from 4 to 12 h using the 
rotating basket method specified in USP XXI at 100 
rpm. Microspheres equivalent to 100 mg of drug were 
placed in the basket and the medium was maintained at 
37±0.50C. An aliquot of 10 ml were withdrawn 
periodically at intervals of one h and same volume of 
fresh medium was replaced. The concentration of the 
drug released at different time intervals was determined 
by measuring the absorbance at 366.4 nm [6]. 
 
IR Analysis 
IR studies of drug and microspheres were carried out 
by IR Spectrophotometer and record the spectra in the 
IR region of 4000-625 cm−1. Compare the position and 
relative intensity of the absorption band of the 
microspheres and pure tinidazole. 
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Result and discussion 
Morphology 
The result shows microspheres were spherical in shape 
with smooth surface [Figure 1]. 
 
 
 
         Figure 1. SEM images of microspheres 
 
Size analysis 
Results of all four formulation showed that particle size 
of prepared microspheres was in the range of 33.28 μm 
to 36.25 μm so it was concluded that particle size of 
prepared microspheres increases with increase in 
polymer concentration as shown in table 2. 
 
Melting point 
The melting point of free drug and drug inside the 
microspheres were found to be 1260C and and 1310C 
respectively. The melting point of free drug and 
microspheres are very close, this shows that after 
entrapment inside the formulation drug retain its 
behavior and nature as its original free state i.e. no 
change in the nature of drug. 
Table 2. Data of particle size analysis. 
 
Batch code Particle size (in µm) 
A-1 33.28 
A-2 35 
A-3 35.14 
A-4 36.25 
 
Thin layer chromatography 
TLC was done to check the drug stability in the 
microspheres. The Rf value of drug and microspheres 
were found to be 0.820 and 0.811 respectively. So they 
show that process does not affect drug stability. 
 
Drug content determination 
First two batches shows entrapment of drug near to 
50% whereas last two batches shows entrapment  more 
than 70%.This shows that drug entrapment increases 
with increase in amount of the polymer [Table 3]. 
 
Table3. Data of drug content. 
 
Batch code % Drug Entrapment 
A-1 48 
A-2 55 
A-3 75 
A-4 78 
 
In vitro Drug release studies 
The drug release is controlled over 18 hours from all 
batches. The release from 1:4 batch is most constant 
and prolonged over time. From all the batches it is 
concluded that when concentration of polymer 
increases. Microspheres show more controlled and 
prolonged release. Drug release study shows that for a 
fixed time hours, microspheres varies its drug release, 
after that drug release become stagnant [Table 4 and 
Fig 2 (a-d)]. 
 
Table 4. Data of drug release analysis. 
                                      
Batch code % Drug release after 18 h 
A-1 66 
A-2 51 
A-3 48 
A-4 42 
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(a) (b) 
 
(c) (d) 
 
Figure 2. Release profile of batch (a) A-1, (b) A-2, (c) A-3 and (d) A-4 
 
IR analysis 
Both the spectra of drug and formulation were almost 
same. Combination multitone recorded due to N=O 
stretching and S=O in the IR region of 1500-1250 
cm−1. In between 1750-1500 cm−1 peaks recorded due 
to C=C. 
                      
Conclusion 
From the present study it was concluded that 
biodegradable microspheres of tinidazole can be 
prepared using emulsion cross linking method. The 
drug entrapment is around 50% in first two batches 
while in last two batches it reaches up to 78%. This 
concluded that when the polymer concentration 
increases, drug entrapment efficiency also increases. 
Drug release from all the batches varies between 42 to 
66%. Batch 1:4 shows more constant release. This 
concluded that when the polymer concentration 
increases drug release will be more constant and 
prolonged. 
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